Determining the level of competition in the immunosuppressant market segment in the Republic of Uzbekistan

This study focuses on the competitive environment of the immunosuppressant medicines market in the Republic of Uzbekistan. The analysis was based on consolidated data from “Drug-Audit” covering the period from 2017 to 2025. Changes in market concentration and the competitive structure of the segment were examined over the study period. The Herfindahl–Hirschman Index (HHI) was applied to assess the degree of market concentration quantitatively. The results provide an overview of how the market positions of the leading manufacturers have changed and highlight the main features and development trends of competition within the immunosuppressant medicines segment.

Hali tarjima qilinmagan